These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1175747)

  • 1. Inhibition of adriamycin cardiotoxicity by acetyldaunomycin.
    Zbinden G
    Experientia; 1975 Sep; 31(9):1058-60. PubMed ID: 1175747
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective inhibition of rat and human cardiac guanylate cyclase by doxorubicin (adriamycin): possible link to anthracycline cardiotoxicity.
    Levey GS; Levey BA; Ruiz E; Lehotay DC
    Trans Assoc Am Physicians; 1979; 92():303-8. PubMed ID: 44927
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular effects of doxorubicin (Adriamycin) and 4-demethoxydaunorubicin (Idarubicin) in the conscious rat.
    Christoffersen PS; Rasmussen KK; Hermansen K
    Pharmacol Toxicol; 1988 Jan; 62(1):54-6. PubMed ID: 3162769
    [No Abstract]   [Full Text] [Related]  

  • 4. Decreased cardiac toxicity of adriamycin and daunorubicin when bound to DNA.
    Langslet A; Oye I; Lie SO
    Acta Pharmacol Toxicol (Copenh); 1974 Nov; 35(5):379-85. PubMed ID: 4479715
    [No Abstract]   [Full Text] [Related]  

  • 5. [Suppression of DNA synthesis in mice by the anthracycline antibiotics daunorubicin, carminomycin and doxorubicin].
    Reznikova MI; Dudnik IuV
    Antibiot Khimioter; 1988 Apr; 33(4):286-9. PubMed ID: 3389958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition of rat and human cardiac guanylate cyclase in vitro by doxorubicin (adriamycin): possible link to anthracycline cardiotoxicity.
    Levey GS; Levey BA; Ruiz E; Lehotay DC
    J Mol Cell Cardiol; 1979 Jun; 11(6):591-9. PubMed ID: 37344
    [No Abstract]   [Full Text] [Related]  

  • 7. Toxicologic screening of daunorubicin (NSC-82151), adriamycin (NSC-123127), and their derivatives in rats.
    Zbinden G; Brändle E
    Cancer Chemother Rep; 1975; 59(4):707-15. PubMed ID: 1175165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of studies with adriamycin (NSC-123127).
    Bachur NR
    Cancer Chemother Rep 3; 1973 May; 4(3):47-50. PubMed ID: 4795942
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetic, toxicologic, and chemotherapeutic properties of detorubicin in mice: a comparative study with daunorubicin and adriamycin.
    Deprez-de Campeneere D; Baurain R; Trouet A
    Cancer Treat Rep; 1979 May; 63(5):861-7. PubMed ID: 455327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of new anthracycline antibiotics, aclacinomycin-A and its analogs, and their toxicity.
    Hori S; Shirai M; Hirano S; Oki T; Inui T; Tsukagoshi S; Ishizuka M; Takeuchi T; Umezawa H
    Gan; 1977 Oct; 68(5):685-90. PubMed ID: 579346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electron microscopic studies of the heart and light microscopic studies of the skin after treatment of golden hamsters with adriamycin, detorubicin, AD-32, and aclacinomycin.
    Dantchev D; Slioussartchouk V; Paintrand M; Hayat M; Bourut C; Mathé G
    Cancer Treat Rep; 1979 May; 63(5):875-88. PubMed ID: 455329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiotoxicity of adriamycin and related anthracyclines.
    Lenaz L; Page JA
    Cancer Treat Rev; 1976 Sep; 3(3):111-20. PubMed ID: 822941
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of oxidative phosphorylation in tumor cells and mitochondria by daunomycin and adriamycin.
    Mailer K; Petering DH
    Biochem Pharmacol; 1976 Sep; 25(18):2085-9. PubMed ID: 985547
    [No Abstract]   [Full Text] [Related]  

  • 14. Distribution and metabolism of daunomycin, adriamycin, and N-acetyldaunomycin in the Syrian golden hamster.
    Mhatre RM; Herman EH; Waravdekar VS; Lee IP
    Biochem Med; 1972 Oct; 6(5):445-53. PubMed ID: 5075698
    [No Abstract]   [Full Text] [Related]  

  • 15. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin.
    Gewirtz DA
    Biochem Pharmacol; 1999 Apr; 57(7):727-41. PubMed ID: 10075079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of adriamycin on the activity of the succinate dehydrogenase-coenzyme Q10 reductase of the rabbit myocardium.
    Bertazzoli C; Sala L; Ballerini L; Watanabe T; Folkers K
    Res Commun Chem Pathol Pharmacol; 1976 Dec; 15(4):797-800. PubMed ID: 1005920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrocardiographic and transmembrane potential effects of 5-iminodaunorubicin in the rat.
    Jensen RA; Acton EM; Peters JH
    Cancer Res; 1984 Sep; 44(9):4030-9. PubMed ID: 6744318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective mitochondrial alterations induced by a single dose of daunorubicin or 4-demethoxydaunorubicin in mouse ventricular myocardium.
    Zanon PL; Lambertenghi-Deliliers G; Pozzoli EF; Nava M; Soligo DA; Praga C; Di Marco A
    Tumori; 1980 Feb; 66(1):27-34. PubMed ID: 6929617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial NADH dehydrogenase-catalyzed oxygen radical production by adriamycin, and the relative inactivity of 5-iminodaunorubicin.
    Davies KJ; Doroshow JH; Hochstein P
    FEBS Lett; 1983 Mar; 153(1):227-30. PubMed ID: 6298008
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of cardiac guanylate cyclase by doxorubicin and some of its analogs: possible relationship to cardiotoxicity.
    Lehotay DC; Levey BA; Rogerson BJ; Levey GS
    Cancer Treat Rep; 1982 Feb; 66(2):311-6. PubMed ID: 6120040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.